|
Post by lcd on Feb 9, 2015 22:46:28 GMT
I admittedly don't know what else is out there in clinical trials for ALS but I saw this today and want to share. Genervon Biopharmaceuticals was approved for a single compassionate use case (after completing double-blind P2 trials) and has submitted results back to the FDA. www.businesswire.com/news/home/20150108005470/en/Genervon-Announces-ALS-Compassionate-Results#.VNk3N2jF81JCUR's results are open label and BCLI's are from Israel so I don't see either of them getting approved until they have another set of trial results complete.
|
|